RSLS - ReShape Lifesciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-81,151.575-33,817.972-23,360.844-25,498.747
Operating Activities, Cash Flows Provided By or Used In
Depreciation440.557268.155139.576189.491
Adjustments To Net Income52,363.6327,760.815-1,161.8793,644.241
Changes In Accounts Receivables-507.89528.103-105.625-55.116
Changes In Liabilities317.081-223.4351,139.656-222.636
Changes In Inventories1,977.651-178.968-103.254-705.805
Changes In Other Operating Activities-929.6211,575.094960.237-783.203
Total Cash Flow From Operating Activities-27,490.17-24,588.208-20,655.793-22,606.04
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-49.579-137.123-14-38.915
Investments----
Other Cash flows from Investing Activities--4,381.847-4,381.847-4,381.847
Total Cash Flows From Investing Activities-10,328.386-6,367.69-14-38.915
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings--16,803.133-1,500
Other Cash Flows from Financing Activities-4,555.276-4,525.005-754.793-2,198.904
Total Cash Flows From Financing Activities33,203.09337,808.31916,053.3418,953.028
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-4,615.4636,852.421-4,616.453-3,691.927